The Distribution of Biomedical Research Resources and International Justice
Resnik, David B.
Developing World Bioethics 2004 May; 4(1): 42-57
According to some estimates, less than 10% of the world's biomedical research funds are dedicated to addressing problems that are responsible for 90% of the world's burden of disease. This paper explains why this disparity exists and what should be done about it. It argues that the disparity exists because: 1) multinational pharmaceutical and biotechnology companies do not regard research and development investments on the health problems of developing nations to be economically lucrative; and 2) governmental agencies that sponsor biomedical research face little political pressure to allocate funds for the problems of developing nations. This paper argues that developed nations have an obligation to address disparities related to biomedical research funding. To facilitate this effort, developed countries should establish a trust fund dedicated to research on the health problems of developing nations similar to the Global AIDS Fund.
Showing items related by title, author, creator and subject.
Is Human Subjects Research (Ethics) in Crisis? Review of the ETHICS of BIOMEDICAL RESEARCH: AN INTERNATIONAL PERSPECTIVE, by Baruch A. Brody; BEYOND CONSENT: SEEKING JUSTICE in RESEARCH, Edited by Jeffrey P. Kahn, Anna C. Mastroianni, And Jeremy Sugarman; ETHICS of RESEARCH WITH HUMAN SUBJECTS: SELECTED POLICIES and RESOURCES, Edited by Jeremy Sugarman, Anna C. Mastroianni, and Jeffrey P. Kahn Merz, Jon F. (2000-10)
Privatized biomedical research, public fears, and the hazards of government regulation: lessons from stem cell research Resnik, David B. (1999)This paper discusses the hazards of regulating controversial biomedical research in light of the emergence of powerful, multi- national biotechnology corporations. Prohibitions on the use of government funds can simply ...